A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients.

Naoki FukudaKazuhisa TodaShohei UdagawaAkihiro OhmotoRyosuke OkiHirotaka SutoXiaofei WangNaomi HayashiTetsuya UrasakiYasuyoshi SatoKenji NakanoMakiko OnoJunichi TomomatsuHiroki MitaniShunji Takahashi

Published in: Endocrine (2022)

Our proposed scoring system can separate treatment outcomes and prognosis of RR-DTC patients treated with lenvatinib. This simple algorithm can be helpful for oncologists in deciding whether to start lenvatinib treatment in patients with RR-DTC.

Keyphrases

machine learning
deep learning
palliative care
combination therapy
replacement therapy
advanced cancer